MedTrace Logo

A New and Innovative Method for CO2 Removal in Anesthetic Circuits

NCT03014336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 286

Last updated 2026-02-23

Study results available
· View outcomes & findings →

Summary

The drawbacks of chemical CO2 absorbers include the production of compounds harmful to patients that also lead into increased cost and environmental impact, as well as the daily disposal of compound special waste. Sustainable management of general anesthesia is a growing concern. Continually diluting anesthetic circuits, and the disposal of chemical granulate are serious environmental problems.

Conditions

  • Anesthesia

Interventions

DEVICE

memsorb

memsorb is a CO2 filter replacing current chemical CO2 absorbers

Sponsors & Collaborators

  • DMF Medical Incorporated

    lead INDUSTRY

Principal Investigators

  • Orlando Hung, MD · Nova Scotia Health Authority

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-20
Primary Completion
2022-05-10
Completion
2024-07-24

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03014336 on ClinicalTrials.gov